Spire Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35
Closed -$10.6K 2268
2025
Q4
$10.6K Hold
35
﹤0.01% 1686
2025
Q3
$9.81K Buy
35
+13
+59% +$3.54K ﹤0.01% 1757
2025
Q2
$5.31K Sell
22
-13
-37% -$3.07K ﹤0.01% 1924
2025
Q1
$8.53K Sell
35
-28
-44% -$8.42K ﹤0.01% 1885
2024
Q4
$20.7K Sell
63
-2
-3% -$679 ﹤0.01% 1613
2024
Q3
$21.7K Buy
65
+1
+2% +$318 ﹤0.01% 1415
2024
Q2
$17.5K Buy
64
+55
+611% +$16K ﹤0.01% 1490
2024
Q1
$3.11K Sell
9
-63
-88% -$20.7K ﹤0.01% 2019
2023
Q4
$22.1K Sell
72
-3
-4% -$940 ﹤0.01% 1496
2023
Q3
$26.9K Buy
75
+7
+10% +$2.7K ﹤0.01% 1391
2023
Q2
$25.8K Buy
68
+24
+55% +$9.77K ﹤0.01% 1481
2023
Q1
$21.1K Buy
44
+18
+69% +$8.43K ﹤0.01% 1594
2022
Q4
$11K Buy
26
+18
+225% +$7.26K ﹤0.01% 1564
2022
Q3
$3K Hold
8
﹤0.01% 1846
2022
Q2
$4K Hold
8
﹤0.01% 2171
2022
Q1
$5K Sell
8
-25
-76% -$15.1K ﹤0.01% 2220
2021
Q4
$25K Buy
33
+25
+313% +$18.7K ﹤0.01% 2032
2021
Q3
$6K Hold
8
﹤0.01% 2223
2021
Q2
$5K Sell
8
-6
-43% -$3.65K ﹤0.01% 2298
2021
Q1
$8K Buy
+14
New +$8.29K ﹤0.01% 2466

Other funds holding BIO

Spire Wealth Management's BIO Position: Q1 2026 in Review

Spire Wealth Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 35 shares — an estimated $10.6K sold.

Spire Wealth Management first reported a position in BIO in Q1 2021 and held it in 20 quarters. The position peaked at $26.9K in Q3 2023. 395 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Spire Wealth Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • Spire Wealth Management sold 35 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $10.6K.
  • Spire Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q1 2021 and held it in 20 quarters.
  • Spire Wealth Management's Bio-Rad Laboratories Class A position peaked at $26.9K in Q3 2023.
  • 395 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Spire Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.